There's an exciting study underway in Israel testing the effects of medical marijuana on autism. Nearly half of the participants of the study had responded negatively to anti-psychotic medications. There has been substantial anecdotal data to support the use of cannabidiol (CBD) for autism, and this clinical study led by Dr. Adi Aran intends to determine if there is in fact a link between CBD and autism symptoms. There are 120 children and young adults between the ages of 5 and 29 who are participating in the study, all of which have a form of autism ranging between mild and severe. Participants receive drops of either a placebo, or one of two different CBD variations, which they mix into food. The study is on track to conclude this year.
Stay tuned to see what is to come of this study. This information has been provided by High Times Magazine and approved by our Chief Medical Officer.